ArchCare Extends Contract with Tabula Rasa HealthCare for Medication Safety, Efficacy, and Adherence Services

Rhea-AI Summary

Tabula Rasa HealthCare (TRHC) has announced a five-year contract renewal with ArchCare Senior Life to provide pharmacy and medication management services. ArchCare serves over 700 participants in the New York metro region and will continue using TRHC's MedWise technology to identify multi-drug interactions and improve medication safety. This partnership has been instrumental in enhancing ArchCare's pharmacy practices and patient outcomes. TRHC's solutions, including MedWise, aim to combat medication overload and reduce adverse drug events, which are significant concerns in healthcare.

Positive

• Five-year contract renewal with ArchCare enhances long-term partnership.
• TRHC's MedWise technology supports improved medication safety and efficacy.
• ArchCare benefits from reduced administrative time and better participant outcomes.

Negative

• None.

MOORESTOWN, N.J., June 2, 2021 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announced a five year contract renewal with ArchCare Senior Life, a Program of All-Inclusive Care for the Elderly (PACE) serving more than 700 participants from multiple centers throughout the New York metro region.

ArchCare will continue to rely on TRHC's pharmacy and medication management services, including its medication decision-support technology, MedWise®, to identify simultaneous, accumulative, multi-drug interactions. Using MedWise, embedded in TRHC's PACE-specific software, ArchCare providers are able to make informed decisions at the point of prescribing to improve medication safety, efficacy, and adherence. By extending this long-standing relationship, ArchCare will continue to have access to certified MedWise Advisor™ (CMWA) pharmacists who provide recommendations for interventions that reduce risks and improve medication outcomes.

"When we began our relationship with Tabula Rasa we needed a scaleable, innovative partner to help us improve our pharmacy practices and grow our PACE presence. Since the start, Tabula Rasa has delivered in every way," said Michael Crismali, MD, Medical Director at ArchCare. "When it came time for us to consider who could best help us deliver high-quality, efficient care to our participants into the future, our decision was clear."

ArchCare will continue to benefit from TRHC's life-extending medication management platform, enhanced multi-dose adherence packaging, and home delivery services, saving thousands of hours of administrative time and helping to drive better participant outcomes.

"We are thrilled that TRHC's MedWise technology continues to promote the safe use of medication among our partners, like ArchCare, in PACE organizations and beyond," said TRHC Chairman and CEO, Calvin H. Knowlton, PhD. "Our unique medication safety platform, MedWise, helps pharmacists and prescribers optimize medication regimens and reduce adverse drug events." 

About Tabula Rasa HealthCare
Tabula Rasa HealthCare (TRHC) provides medication safety solutions that empower healthcare professionals and consumers to optimize medication regimens, combatting medication overload and reducing adverse drug events – the fourth leading cause of death in the US. TRHC's proprietary technology solutions, including EireneRx® and MedWise®, improve patient outcomes, reduce hospitalizations, and lower healthcare costs. TRHC's extensive clinical tele-pharmacy network improves care for patients nationwide. Its solutions are trusted by health plans and pharmacies to help drive value-based care. For more information, visit TRHC.com.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/archcare-extends-contract-with-tabula-rasa-healthcare-for-medication-safety-efficacy-and-adherence-services-301303152.html

SOURCE Tabula Rasa HealthCare, Inc.

FAQ

What is the significance of TRHC's contract renewal with ArchCare?

The renewal solidifies a five-year partnership, enhancing medication safety and management for over 700 participants.

How will TRHC's MedWise technology benefit ArchCare?

MedWise technology will help identify multi-drug interactions, improving medication safety and adherence.

When was the contract renewal between TRHC and ArchCare announced?

The contract renewal was announced on June 2, 2021.

What services will TRHC provide under the contract with ArchCare?

TRHC will provide pharmacy and medication management services, including medication decision-support technology.

How does TRHC aim to improve patient outcomes?

TRHC aims to optimize medication regimens and reduce adverse drug events through its innovative technology solutions.